How Merck Is Trying to Keep Disrupters at Bay
Harvard Business Review
JUNE 8, 2015
EB operates Ilum as a separate business, while still drawing on Merck’s established corporate resources in IT, finance, privacy, compliance, and legal. It has also abandoned other initiatives, and that’s equally important in managing innovation in a corporate context. It’s not just products.
8 
Let's personalize your content